Credit Suisse advice for Vertex Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| February 13, 2018 | Credit Suisse | Vertex Pharma | Buy | 196.00 USD | 6.52 % |
Advice details
Zurich - Op 13 feb herhalen de analisten van Credit Suisse hun koopadvies voor Vertex Pharma (ISIN: US92532F1003 / Mnemo: VRTX). Het 12-maands koersdoel wordt opwaarts bijgesteld van 151.0 USD naar 196.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 